Louise Kuhn1, Hae-Young Kim1, Lauren Hsiao2, Caroline Nissan2, Chipepo Kankasa3, Mwiya Mwiya3, Donald M Thea4, Grace M Aldrovandi5, Lars Bode6. 1. Gertrude H Sergievsky Center and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY; 2. Division of Neonatal Medicine and Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, University of California, San Diego, San Diego, CA; 3. University Teaching Hospital, University of Zambia, Lusaka, Zambia; 4. Center for International Health and Development, Boston University School of Public Health, Boston, MA; and. 5. Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA. 6. Division of Neonatal Medicine and Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, University of California, San Diego, San Diego, CA; lbode@ucsd.edu.
Abstract
BACKGROUND: Human milk oligosaccharides (HMOs) have multiple immunomodulatory functions that influence child health. OBJECTIVE: In this study we investigated whether HMO composition influences survival to 2 y of age in HIV-infected and HIV-exposed, uninfected (HEU) children during and after breastfeeding. METHODS: In the context of an early weaning trial in 958 HIV-infected women in Lusaka, Zambia, we conducted a nested case-cohort analysis of mortality to 2 y of age among 103 HIV-infected and 143 HEU children. Breast-milk samples collected at 1 mo postpartum were analyzed for HMO content. Samples were selected to include mothers of all HIV-infected children detected by 6 wk of age, of whom 63 died at <2 y of age; mothers of all HEU children who died at <2 y of age (n = 66); and a random sample of 77 HEU survivors. Associations before and after weaning in HIV-infected and HEU infants separately were investigated by using Cox models. RESULTS: Among HEU children, higher maternal breast-milk concentrations of 2-linked fucosylated HMOs [2'-fucosyllactose and lacto-N-fucopentaose (LNFP) I] (HR: 0.33; 95% CI: 0.14, 0.74) as well as non-2-linked fucosylated HMOs (3-fucosyllactose and LNFP II/III; HR: 0.28; 95% CI: 0.13, 0.67) were significantly associated with reduced mortality during, but not after, breastfeeding after adjustment for confounders. Breastfeeding was protective against mortality only in HEU children with high concentrations of fucosylated HMOs. Among HIV-infected children, no consistent associations between HMOs and mortality were observed, but breastfeeding was protective against mortality. CONCLUSIONS: The oligosaccharide composition of breast milk may explain some of the benefits of breastfeeding in HEU children. HIV infection may modulate some of the consequences of HMOs on child survival.
BACKGROUND:Human milk oligosaccharides (HMOs) have multiple immunomodulatory functions that influence child health. OBJECTIVE: In this study we investigated whether HMO composition influences survival to 2 y of age in HIV-infected and HIV-exposed, uninfected (HEU) children during and after breastfeeding. METHODS: In the context of an early weaning trial in 958 HIV-infectedwomen in Lusaka, Zambia, we conducted a nested case-cohort analysis of mortality to 2 y of age among 103 HIV-infected and 143 HEU children. Breast-milk samples collected at 1 mo postpartum were analyzed for HMO content. Samples were selected to include mothers of all HIV-infectedchildren detected by 6 wk of age, of whom 63 died at <2 y of age; mothers of all HEU children who died at <2 y of age (n = 66); and a random sample of 77 HEU survivors. Associations before and after weaning in HIV-infected and HEU infants separately were investigated by using Cox models. RESULTS: Among HEU children, higher maternal breast-milk concentrations of 2-linked fucosylated HMOs [2'-fucosyllactose and lacto-N-fucopentaose (LNFP) I] (HR: 0.33; 95% CI: 0.14, 0.74) as well as non-2-linked fucosylated HMOs (3-fucosyllactose and LNFP II/III; HR: 0.28; 95% CI: 0.13, 0.67) were significantly associated with reduced mortality during, but not after, breastfeeding after adjustment for confounders. Breastfeeding was protective against mortality only in HEU children with high concentrations of fucosylated HMOs. Among HIV-infectedchildren, no consistent associations between HMOs and mortality were observed, but breastfeeding was protective against mortality. CONCLUSIONS: The oligosaccharide composition of breast milk may explain some of the benefits of breastfeeding in HEU children. HIV infection may modulate some of the consequences of HMOs on child survival.
Authors: Taha E Taha; Newton I Kumwenda; Donald R Hoover; George Kafulafula; Susan A Fiscus; Chiwawa Nkhoma; Shu Chen; Robin L Broadhead Journal: Bull World Health Organ Date: 2006-07 Impact factor: 9.408
Authors: Lars Bode; Clemens Kunz; Marion Muhly-Reinholz; Konstantin Mayer; Werner Seeger; Silvia Rudloff Journal: Thromb Haemost Date: 2004-12 Impact factor: 5.249
Authors: Ardythe L Morrow; Guillermo M Ruiz-Palacios; Mekibib Altaye; Xi Jiang; M Lourdes Guerrero; Jareen K Meinzen-Derr; Tibor Farkas; Prasoon Chaturvedi; Larry K Pickering; David S Newburg Journal: J Pediatr Date: 2004-09 Impact factor: 4.406
Authors: David S Newburg; Guillermo M Ruiz-Palacios; Mekibib Altaye; Prasoon Chaturvedi; Jareen Meinzen-Derr; Maria de Lourdes Guerrero; Ardythe L Morrow Journal: Glycobiology Date: 2003-11-24 Impact factor: 4.313
Authors: Michelle K McGuire; Courtney L Meehan; Mark A McGuire; Janet E Williams; James Foster; Daniel W Sellen; Elizabeth W Kamau-Mbuthia; Egidioh W Kamundia; Samwel Mbugua; Sophie E Moore; Andrew M Prentice; Linda J Kvist; Gloria E Otoo; Sarah L Brooker; William J Price; Bahman Shafii; Caitlyn Placek; Kimberly A Lackey; Bianca Robertson; Susana Manzano; Lorena Ruíz; Juan M Rodríguez; Rossina G Pareja; Lars Bode Journal: Am J Clin Nutr Date: 2017-03-29 Impact factor: 7.045
Authors: Jasmine F Plows; Paige K Berger; Roshonda B Jones; Tanya L Alderete; Chloe Yonemitsu; Julia A Najera; Sadaf Khwajazada; Lars Bode; Michael I Goran Journal: J Nutr Date: 2021-04-08 Impact factor: 4.687